Abstract:Glycoprotein Ibalpha (GPIbalpha) is a platelet-specific membrane protein. It mediates platelet adhesion to collagen exposed at the vascular injury site by binding to von Willebrand factor (VWF) in plasma. This process is crucial for arterial thrombus formation. Blocking interaction between GPIbalpha and VWF may prevent platelet adhesion and thrombus formation. We previously generated a high affinity monoclonal antibody against human platelet GPIbalpha, SZ2, which inhibits both ristocetin- and botrocetin-induced platelet aggregation in vitro. To convert SZ2 into mouse/human chimeric antibody for anti-platelet therapy in humans, in this study, we constructed a mouse/human chimeric antibody derived from the hybridoma cells producing murine antibody against platelet glycoprotein Ibalpha, conducted its expression in dihydrofolate reductase-deficient Chinese hamster ovary (CHO) cells, and prepared its chimeric Fab fragment. Results from ELISA and Western blot analysis showed that the chimeric antibody was secreted from the cells and that the heavy and light chains were assembled correctly. Flow cytometry analysis confirmed specific binding of the chimeric antibody to the GPIb-expressing CHO cells. In vitro functional studies revealed that the chimeric antibody and its Fab fragment prevented platelet adhesion to VWF under high shear stress and inhibited ristocetin-induced platelet aggregation in a dose-dependent manner. These results demonstrated that the chimeric antibody was successfully engineered and suggested that the Fab fragment of chimeric antibody against GPIbalpha is a promising therapeutic antibody more suitable for prevention and treatment of human arterial thrombosis.

Expression and Characterization of Vwf Binding Domain of Platelet GP Ib#alpha# in {\sl Pichia Pastoris}

Expression, Purification and Characterization of Recombinant Human Coagulation Factor XIIIa in Pichia Pastoris

Cloning, Expression and Characterization of a Novel Gene (P18) from Mycoplasma Bovis

Experimental study of interaction between activated VWF and targeted lipid microbubbles conjugated with recombinant GPⅠba

Experimental Study of Interaction Between Activated VWF and Targeted Lipid Microbubbles Conjugated with Recombinant GPIba

Molecular Cloning of Human Vwf/a1 Gene and Its Expression

Generation and characterization of a recombinant single chain Fv antibody to von Willebrand factor A1 domain from phage display library.

Expression and Characterization of HIV-1 Envelope Glycoprotein in Pichia Pastoris

[Expression of Antibody Fab Against Platelet IIb/IIIa in E.coli and Characterization of Its Biological Activity].

Engineering and Characterization of a Chimeric Anti-platelet Glycoprotein Ibα Monoclonal Antibody and Preparation of Its Fab Fragment

Cloning, Construction of Prokaryotic Expression System and Identification of Vibrio Vulni Ficus Vvha Gene

[Expression and Characterization of Human Vascular Endothelial Growth Factor in Pichia Pastoris].

Expression of tumor necrosis factor receptor-immunoglobulin G1 Fc fusion protein in glycoengineered Pichia pastoris

Expression of Rpk5 in Pichia Pastoris and Its Biological Activity Identification

Expression and Characterization of Recombinant Porcine Β-Defensin-2 Gene in Pichia Pastoris

Expression of human vascular endothelial growth factor receptor Flt-1 extracellular domain 1-3 loop cDNA in Pichia pastoris, purification of the expressed product and detection of its biological activity.

[Expression of Von Willebrand Factor-A3 Domain in E Coli and Its Biological Function].

Construction,expression and Characterization of Recombinant Fusion Protein HSA-PTH(1-34) in Pichia Pastoris

Expression,purification and initial identification of the multi-epitope gene of Plasmodium vivax in Pichia pastoris

Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3) using a reconstituted mammalian cell expression model.

[Cloning and Expression of Hgp44 from Porphyromonas Gingivalis].